Cite

HARVARD Citation

    Gui, S. et al. (2021). Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC. Journal for immunotherapy of cancer. 9 (3), p. . [Online]. 
  
Back to record